Peridural analgesia does not impact survival in patients after colon cancer resection: a retrospective propensity score-adjusted analysis

2019 ◽  
Vol 34 (7) ◽  
pp. 1283-1293 ◽  
Author(s):  
Elena F. Wurster ◽  
Frank Pianka ◽  
Rene Warschkow ◽  
Pia Antony ◽  
Thorsten Brenner ◽  
...  
2013 ◽  
Vol 398 (6) ◽  
pp. 841-849 ◽  
Author(s):  
Ignazio Tarantino ◽  
Kristjan Ukegjini ◽  
Rene Warschkow ◽  
Bruno M. Schmied ◽  
Thomas Steffen ◽  
...  

2020 ◽  
Vol 40 (5) ◽  
pp. 2969-2974
Author(s):  
ENRICO FIORI ◽  
DANIELE CROCETTI ◽  
ANTONIETTA LAMAZZA ◽  
FRANCESCA DE FELICE ◽  
GIORGIA BURRELLI SCOTTI ◽  
...  

2018 ◽  
Vol 50 (2) ◽  
pp. 50-57 ◽  
Author(s):  
Rüdiger Braun ◽  
Claudia Benecke ◽  
Jan Nolde ◽  
Markus Kleemann ◽  
Markus Zimmermann ◽  
...  

2016 ◽  
Vol 114 (1) ◽  
pp. 80-85 ◽  
Author(s):  
Cornelius A. Thiels ◽  
Nimesh D. Naik ◽  
John R. Bergquist ◽  
Blake A. Spindler ◽  
Elizabeth B. Habermann ◽  
...  

2014 ◽  
Vol 32 (30_suppl) ◽  
pp. 307-307
Author(s):  
Christina Edwards Bailey ◽  
Chung-Yuan Hu ◽  
Amanda Cuddy ◽  
Y. Nancy You ◽  
George J. Chang

307 Background: Current colon cancer surveillance guidelines recommend annual imaging for all patients following curative resection. The primary aim of this study is to evaluate variation in surveillance practices following colon cancer resection. Methods: A retrospective cohort study of patients ≥ 66 years old with stage I-III colon cancer that underwent surgical resection in the Surveillance, Epidemiology, and End Results-Medicare linked database (July 2001 through December 2007) with at least 3 years of follow-up was performed. Medicare claims for PET and CT scan of the chest, abdomen and pelvis performed after surgical resection were recorded and analyzed. In order to evaluate the use of definitive treatment (DT) for presumed recurrent disease, we identified patients who had undergone lung, liver, or colorectal resection during follow-up. Results: Of 22,544 patients who underwent primary resection of colon cancer, 13,753 (61.0%) underwent PET and/or CT after resection and 1,109 (4.52%) underwent at least 1 DT. The mean number of imaging performed for patients who did not undergo DT was 1.68. Within this group, the utilization of PET and/or CT varied by stage, with 14.1%, 22.4%, and 42.2% of patients with stage I, II, and III disease undergoing imaging, respectively. The most significant factor associated with PET and/or CT was tumor stage with an odds ratio of 1.86 (95% CI 1.70-2.02, P<0.001) for stage II disease and 4.56 (95% CI 4.17-4.99, P<0.001) for stage III disease compared to stage I disease. Additional factors significantly associated with PET and/or CT included year of diagnosis and SEER region. Among patients who did undergo DT, the mean number of PET and/or CT performed was 5.37 but the majority of imaging studies were performed 4 months prior to DT (mean 2.95). Conclusions: There is a high degree of variation in the use of surveillance imaging among elderly patients with localized colon cancer although some of this variation appears to be associated with stage at presentation. Our findings highlight discordance between clinical practice and surveillance guidelines. Further study is needed to understand the basis and appropriateness of clinical decision making that departs from guideline-based care.


2017 ◽  
Vol 32 (3) ◽  
pp. 1133-1140 ◽  
Author(s):  
Piera Leon ◽  
Michele Giuseppe Iovino ◽  
Fabiola Giudici ◽  
Antonio Sciuto ◽  
Nicolò de Manzini ◽  
...  

2011 ◽  
Vol 106 (3) ◽  
pp. 219-223 ◽  
Author(s):  
Andrew S. Barbas ◽  
Ryan S. Turley ◽  
Christopher R. Mantyh ◽  
John Migaly

Sign in / Sign up

Export Citation Format

Share Document